Rungraungrayabkul D., Okuma N. Oral Immune-Related Adverse Events Following Durvalumab Administration. Oral Diseases (2025). doi:10.1111/odi.70057 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/111581
Title
Oral Immune-Related Adverse Events Following Durvalumab Administration